CBRS20109 / EAZ171 / Alissa Huston
Basic Study Information
Purpose:Location: University of Rochester
This phase II trial studies how well docetaxel or paclitaxel work in reducing chemotherapy-induced
peripheral neuropathy in African American patients with stages I-III breast cancer.
Drugs used in chemotherapy, such as docetaxel and paclitaxel, work in different ways
to stop the growth of tumor cells, either by killing the cells, by stopping them from
dividing, or by stopping them from spreading. It is not yet known whether giving docetaxel
or paclitaxel may work better than other methods in reducing chemotherapy-induced
peripheral neuropathy in patients with breast cancer.
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search